President Donald Trump’s proposed 2027 federal budget is once again putting U.S. science agencies on the chopping block, renewing a contentious debate in Washington over the future of American research and innovation.
For the second consecutive year, the White House is asking Congress to approve sweeping reductions in federal research spending. The proposal outlines deep cuts across nearly every major science agency, including a 55% reduction for the National Science Foundation (NSF), a 23% cut to NASA, a 15% decrease for the Department of Energy’s Office of Science, and a 12% cut to the National Institutes of Health (NIH).
The plan also calls for eliminating a range of programs focused on climate change and environmental research, while placing new limits on how federal agencies spend money on publishing scientific papers and subscribing to academic journals.
A Renewed Push After Congressional Resistance
The proposal closely mirrors the administration’s 2026 budget request, which lawmakers ultimately rejected. Congress, exercising its power over federal spending, restored much of the proposed funding and pushed back against the steepest reductions.
Whether lawmakers will do so again remains uncertain. The 2027 fiscal year does not begin until October 1, leaving months of negotiations ahead. Historically, Congress has shown bipartisan support for maintaining and often increasing federal research investments, but the scale of the proposed cuts could test that consensus.
Research advocates are already mobilizing. The Association of American Universities, representing leading research institutions, urged Congress to once again reject the proposal, calling the cuts “short-sighted” and warning they could undermine the nation’s scientific leadership.
Criticism has also come from Capitol Hill. Representative Zoe Lofgren of California, the top Democrat on the House science committee, dismissed the proposal outright, arguing it would “stymie American science and innovation” and weaken U.S. competitiveness globally.
Defense Spending Up, Civilian Science Down
The science cuts are part of a broader restructuring of federal spending priorities. The administration’s budget blueprint calls for a sharp increase in defense funding, with total discretionary spending rising from approximately $1.6 trillion to $2.2 trillion — a nearly 40% jump.
That increase is largely driven by a parallel 40% boost in defense spending. To offset it, nondefense discretionary spending — which includes scientific research — would fall by about 10%, dropping to $660 billion.
This shift reflects a clear prioritization of national security over domestic investment, including scientific research. Critics argue that such trade-offs could have long-term consequences, particularly as global competitors ramp up their own investments in science and technology.
Impact Across Key Agencies
The proposed cuts would significantly reshape the U.S. research landscape.
The National Science Foundation, a major funder of basic research across disciplines from physics to social sciences, would face the steepest reduction at 55%. Such a cut could dramatically shrink grant funding, affecting universities and early-career researchers nationwide.
NASA’s 23% reduction could impact space exploration, Earth science missions, and technology development. Programs related to climate monitoring and environmental observation appear particularly vulnerable under the proposal.
At the Department of Energy, the Office of Science — which supports national laboratories and large-scale physics and energy research — would see a 15% decrease. Meanwhile, the NIH, the world’s largest public funder of biomedical research, would lose 12% of its budget, potentially slowing progress in areas such as cancer, neuroscience, and infectious diseases.
Beyond funding levels, the proposal introduces policy changes that could alter how science is conducted and disseminated. By limiting spending on journal subscriptions and publishing, the administration is signaling a shift in how federally funded research is shared — a move that could have ripple effects across academia.
Climate and Environmental Research in Focus
One of the most controversial aspects of the budget is its targeting of climate and environmental programs. The proposal calls for eliminating numerous initiatives in these areas, aligning with broader efforts by the administration to scale back federal involvement in climate-related research and policy.
Supporters of the cuts argue that federal resources should be concentrated on what they describe as “core priorities,” while critics warn that reducing climate research could hinder the country’s ability to respond to environmental challenges and extreme weather events.
Strategic Priorities: AI, Health, and Quantum Computing
Despite the overall reduction in science funding, the administration says it is not abandoning research altogether. Instead, it aims to “recalibrate” federal investments toward selected high-priority areas.
These include artificial intelligence, quantum computing, and certain aspects of health research — fields seen as critical to economic competitiveness and national security. The idea, officials argue, is to focus limited resources on technologies with the greatest strategic impact.
However, many scientists caution that breakthroughs in these areas often depend on sustained investment in basic research — the very category most affected by the proposed cuts.
Uncertain Path Ahead
The fate of the 2027 budget now lies with Congress, where negotiations are expected to be lengthy and politically charged. Lawmakers must balance competing priorities: defense, domestic programs, deficit concerns, and the long-term value of scientific investment.
If past patterns hold, Congress may restore at least some of the proposed cuts. But the scale and scope of the reductions — combined with broader fiscal pressures — make the outcome far from certain.
For now, the proposal has reignited a familiar debate: how much the United States should invest in science, and what role federal funding should play.
Written By Aren Karapetyan, MD